Document:

<PAGE>

                                                                    EXHIBIT 10.3

                                                                    EXHIBIT A
                                                                        TO
                                                                 NOTICE OF GRANT

                          MEMORY PHARMACEUTICALS CORP.

                             Stock Option Agreement
                         Under 2004 Stock Incentive Plan

            Section 1. Grant of Option.

            (a) This Stock Option Agreement (the "Agreement") evidences the
grant by Memory Pharmaceuticals Corp., a Delaware corporation (the "Company"),
on the Grant Date, to the Optionee, of an option (the "Option") to purchase, in
whole or in part, on the terms provided herein and in the Company's 2004 Stock
Incentive Plan (the "Plan"), a total number of shares of the Company's common
stock equal to the Number of Option Shares set forth in the Notice of Grant to
which this Agreement is attached as Exhibit A, at a price per share equal to the
Exercise Price. Unless earlier terminated in accordance with Section 3(c), (d)
or (e) or Section 7 of this Agreement, the Option shall expire at 5:00 p.m.,
Eastern time, on the Termination Date. Capitalized terms used in this Section
1(a) and not otherwise defined herein shall refer to the information set forth
next to such terms on the Notice of Grant. Capitalized terms used in this
Agreement and not otherwise defined in this Agreement or in the Notice of Grant
shall have the meanings assigned to such terms in the Plan, which is attached to
the Notice of Grant as Exhibit B.

            (b) If designated in the Notice of Grant as an Incentive Stock
Option, the Option is intended to qualify as an "incentive stock option" under
Section 422 of the Code.

            (c) Except as otherwise indicated by the context, the term
"Optionee", as used in this Agreement, shall be deemed to include any person who
acquires the right to exercise the Option validly under its terms.

            Section 2. Vesting Schedule.

            (a) The Option will become exercisable as described under the
heading "Vesting" in the Notice of Grant.

            (b) The right of exercise shall be cumulative so that, to the extent
the Option is not exercised in any period to the maximum extent permissible, it
shall continue to be exercisable, in whole or in part, with respect to all
vested Option Shares until the earliest to occur of (i) the Termination Date,
(ii) the termination of the Option under Section 3 or Section 7 hereof, or (iii)
any other termination of the Option under the Plan.

            Section 3. Exercise of Option.

            (a) Form of Exercise. In order to exercise the Option with respect
to all or any part of the Option Shares, the Optionee (or any other person or
persons exercising the Option in

<PAGE>

accordance with Section 3(d)) must execute and deliver to the Company an
election notice in the form of Schedule 1 to this Agreement, either in writing
or electronically, accompanied by payment in full in a manner provided in
Section 4. The Optionee may purchase any number of vested Option Shares subject
to the Option, in any exercise of the Option, provided that no partial exercise
of the Option may be for any fractional share.

            (b) Continuous Relationship with the Company Required. Except as
otherwise provided in this Section 3, the Option may not be exercised unless the
Optionee, at the time he or she exercises the Option, is, and has been at all
times since the Grant Date, a Service Provider.

            (c) Termination of Relationship with the Company. If the Optionee
ceases to be a Service Provider for any reason while the Option is outstanding,
then, except as provided in Sections 3(d) and (e), the right to exercise the
Option shall terminate three months after such cessation (but in no event after
the Termination Date), provided that the Option shall be exercisable only to the
extent and with respect to the number of Option Shares that the Optionee was
entitled to exercise on the date of such cessation.

            (d) Exercise Period Upon Death or Disability. If the Optionee dies
or suffers a Disability while the Option is outstanding (including within the
three-month period following termination of Service of the Optionee), and the
Company has not terminated the Optionee's Service for "Cause" as specified in
Section 3(e), the Option shall be exercisable, within the period of one year
following the date of termination of Service of the Optionee, (i) in the case of
a termination of Service due to the Disability of the Optionee, by the Optionee,
and (ii) in the case of a termination of Service due to the death of the
Optionee, by (A) a beneficiary designated in writing by the Optionee to the
Company prior to the Optionee's death, or (B) if no such beneficiary has been
designated, by the personal representative of the Optionee's estate or by the
person(s) to whom the Option is transferred pursuant to the Optionee's will or
in accordance with the laws of descent and distribution; provided, that, in any
case, the Option shall be exercisable only to the extent and with respect to the
number of Shares that the Optionee was entitled to exercise on the date of his
or her death or Disability; and further provided, that the Option shall not be
exercisable after the Termination Date.

            (e) Discharge for Cause. If the Optionee's Service with the Company
is terminated for Cause while the Option is outstanding, the right to exercise
the Option shall terminate immediately upon the effective date of such
discharge. "Cause" shall mean willful misconduct by the Optionee or willful
failure by the Optionee to perform his or her responsibilities to the Company
(including, without limitation, breach by the Optionee of any provision of any
employment, consulting, advisory, nondisclosure, non-competition or other
similar agreement between the Optionee and the Company), as determined by the
Company, which determination shall be conclusive; provided, however, that if any
definition of "Cause" for termination (or a similar term) is contained in an
effective employment agreement or similar agreement between the Company and the
Optionee at the time of termination, such definition shall supersede the
definition in this Section 3(e) and shall be incorporated in this Section 3(e)
as the definition of "Cause." If the Company determines, within 30 days
following any resignation by the Optionee for "Cause," that discharge of the
Optionee was warranted at the time of such resignation, then the Optionee shall
be considered to have been discharged for "Cause."

                                       2
<PAGE>

            (f) Limited Exercisability. During any period of post-Service
exercisability, the Option may not be exercised in the aggregate for more than
the number of Option Shares in which the Optionee is, at the time of the
Optionee's cessation of Service, vested in accordance with the Vesting Schedule
specified in the Notice of Grant. Upon the expiration of such exercise period or
(if earlier) upon the Termination Date, the Option shall terminate and cease to
be outstanding for any vested Option Shares for which the Option has not been
exercised. To the extent that the Optionee is not vested in the Option Shares at
the time of the Optionee's cessation of Service, the Option shall immediately
terminate and cease to be outstanding with respect to the Option Shares.

            Section 4. Method of Payment.

            (a) Common Stock purchased upon exercise of the Option may be paid
in any one or more of the following forms:

            (i) cash or check made payable to the Company;

            (ii) subject to Section 4(b), by the tendering to the Company of
      other shares of Common Stock of the Company ("Tendered Shares") or the
      attestation to the ownership of shares of Common Stock that otherwise
      would be Tendered Shares ("Attested Shares") in exchange for the Company's
      reducing the number of shares necessary for payment in full of the
      Exercise Price for the Option Shares so purchased; or

            (iii) by the Optionee's (A) irrevocable instructions to the Company
      to deliver the Option Shares issuable upon exercise of the Option promptly
      to a broker (acceptable to the Company) for the Optionee's account, and
      (B) irrevocable instructions to such broker to sell Option Shares
      sufficient to pay the Exercise Price and upon such sale to deliver the
      Exercise Price to the Company, provided, that at the time of such
      exercise, such exercise would not subject the Optionee to liability under
      Section 16(b) of the Exchange Act or would be exempt pursuant to Rule
      16b-3 promulgated under the Exchange Act or any other exemption from such
      liability; the Company shall deliver an acknowledgement to such broker
      upon receipt of instructions to deliver the Option Shares and the Company
      shall deliver the Option Shares to such broker upon the settlement date;
      such broker shall deliver to the Company cash sale proceeds sufficient to
      cover the Exercise Price upon receipt of the Option Shares from the
      Company; or

            (b) Tendered Shares or Attested Shares must be held by the Service
Provider for at least six months prior to their tender or their attestation to
the Company. For purposes of determining the amount of the Exercise Price
satisfied by the Tendered Shares or the Attested Shares, such shares shall be
valued at their Fair Market Value on the date of tender or attestation, as
applicable. Except as provided in this Section 4(b), the date of exercise shall
be deemed to be the date that the notice of exercise and payment of the Exercise
Price are received by the Administrator.

            (c) Prior to the delivery of any Shares or cash pursuant to the
Option (or exercise thereof), the Company shall have the power and the right to
deduct or withhold, or require the Optionee to remit to the Company, an amount
sufficient to satisfy federal, state, and local taxes

                                       3
<PAGE>

(including the Optionee's FICA obligation) required to be withheld with respect
to the Option (or exercise thereof). To the extent that the Company is required
by Applicable Law to withhold funds for taxes in respect of any exercise of the
Option, then the aggregate Exercise Price shall not be deemed paid and the
Option shall not be deemed exercised and the Option Shares issuable upon
exercise shall not be deemed issued, until the Optionee has paid to the Company,
in a manner provided in this Section 4, the aggregate amount of such tax
withholding.

            Section 5. Disqualifying Disposition. If the Optionee disposes of
Option Shares acquired upon exercise of the Option within two years from the
Grant Date or one year after such Option Shares were acquired pursuant to
exercise of the Option, the Optionee shall notify the Company in writing of such
disposition.

            Section 6. Nontransferability of Option. The Option may not be sold,
pledged, assigned, hypothecated, transferred, or disposed of in any manner by
the Optionee, either voluntarily or by operation of law, other than by will or
the laws of descent and distribution, and, during the lifetime of the Optionee,
the Option shall be exercisable only by the Optionee.

            Section 7. Reorganization Event.

            (a) Upon the occurrence of a Reorganization Event, the Option shall
be assumed or an equivalent option substituted by the successor corporation or a
Parent or Subsidiary of the successor corporation.

            (b) Notwithstanding Section 7(a), in the event that the successor
corporation does not assume (within the meaning of Section 9.2 of the Plan) the
Option or an equivalent option is not substituted, then the Administrator shall,
upon written or electronic notice to the Optionee, provide that either: (i) the
Option will become exercisable in full as of a specified time prior to the
Reorganization Event and will terminate immediately prior to the consummation of
such Reorganization Event, except to the extent exercised by the Optionee prior
to the consummation of the Reorganization Event; or (ii) the Option will
terminate upon consummation of such Reorganization Event and the Optionee will
receive, in exchange therefor, a cash payment equal to the amount (if any) by
which (A) the Acquisition Price multiplied by the number of Option Shares
subject to the Option, whether or not such Option Shares are then vested in
full, exceeds (B) the aggregate Exercise Price of the Option.

            (c) If the Option is assumed in connection with a Reorganization
Event, then the Option shall be appropriately adjusted, immediately after such
Reorganization Event, to apply to the number and class of securities which would
have been issuable to the Optionee in consummation of such Reorganization Event
had the Option been exercised in full immediately prior to such Reorganization
Event, and appropriate adjustments shall also be made to the Exercise Price,
provided that the aggregate Exercise Price shall remain the same.

            (d) If either (i) in connection with a Reorganization Event, the
Company or a successor corporation (or a Parent or Subsidiary of the successor
corporation) does not offer to continue the Service of the Optionee in a
position and on terms (including compensation, benefits, work location and
responsibilities) substantially similar to (or more favorable than) the

                                       4
<PAGE>

position and terms on which the Optionee was providing Service to the Company
immediately prior to the Reorganization Event, or (ii) within one year after a
Reorganization Event in which the Optionee's Service is so continued and the
Option is assumed, the Service of the Optionee is terminated, then the Option
shall become fully exercisable upon such event or termination; provided, that no
such acceleration shall occur if the Optionee's Service is terminated for Cause.

            (e) This Agreement shall not in any way affect the right of the
Company to adjust, reclassify, reorganize or to otherwise change its capital or
business structure or to merge, consolidate, dissolve, liquidate or sell or
transfer all or any part of its business or assets.

            Section 8. Adjustments. In the event that there is any stock
dividend that is paid on Common Stock in shares of Common Stock, or any stock
split, reverse stock split, combination or reclassification of Common Stock, or
any other increase in the number of outstanding shares of Common Stock without
receipt of consideration by the Company, then the total number and/or class of
securities subject to the Option and the Exercise Price of the Option shall be
appropriately adjusted, in such manner as the Administrator in its sole
discretion deems equitable, in order to prevent dilution or enlargement of the
rights of the Optionee under the Option.

            Section 9. Stockholder Rights. The holder of the Option shall not
have any rights as a stockholder with respect to the Option Shares until such
person shall have exercised the Option, paid the Exercise Price and become the
record holder of the purchased Shares in accordance with the terms of this
Agreement and the Plan.

            Section 10. Notices. Any notices required or permitted by the terms
of this Agreement or the Plan shall be given by recognized courier service,
facsimile, registered or certified mail, return receipt requested, or electronic
transmission, addressed as follows:

            If to the Company:  Memory Pharmaceuticals Corp.
                                100 Phillips Parkway
                                Montvale, NJ 07645
                                Attn: Chief Financial Officer
                                keane@memorypharma.com

            If to the Optionee: At the address set forth in the Notice of Grant

or to such other address or addresses of which notice in the same manner has
previously been given. Any such notice shall be deemed to have been given upon
the earlier of receipt, one business day following delivery to a recognized
courier service or three business days following mailing by registered or
certified mail.

            Section 11. Governing Law. This Agreement shall be construed and
enforced in accordance with the law of the State of Delaware, without giving
effect to the conflict of law principles thereof.

            Section 12. Successors and Assigns. Subject to the provisions of the
Plan and the other provisions hereof, this Agreement shall be for the benefit of
and shall be binding upon the heirs, executors, administrators, successors and
assigns of the parties hereto.

                                       5
<PAGE>

            Section 13. Construction. This Agreement and the Option evidenced
hereby and by the Notice of Grant are made and granted pursuant to the Plan and
are in all respects limited by and subject to the terms of the Plan. All
decisions of the Administrator with respect to any question or issue arising
under the Plan or this Agreement shall be conclusive and binding on all persons
having an interest in the Option.

                                       6
<PAGE>

                                                                   SCHEDULE 1 to
                                                          STOCK OPTION AGREEMENT

NOTICE OF EXERCISE

TO: Memory Pharmaceuticals Corp. (the "Company")

            Reference is made to the Notice of Grant, dated __________, 20___,
evidencing an Option (the "Option") to purchase an aggregate of _________ shares
of Common Stock of the Company at an exercise price of $____ per share.
Capitalized terms used but not defined in this Notice of Exercise have the
meanings given to them in the Notice of Grant and the accompanying Option
Agreement and Plan.

            I understand the nature of the investment I am making and the
financial risks thereof. I am aware that it is my responsibility to have
consulted with competent tax and legal advisors about the relevant national,
state and local income tax and securities laws affecting the exercise of the
Option and the purchase and subsequent sale of the Option Shares.

            I am paying the Exercise Price for the exercised Option Shares, in
accordance with Section 4 of the Option Agreement, as follows:

            ________________________________________________________

            ________________________________________________________

            Please issue the stock certificate for the Option Shares
            (check one):

            [ ]  to me; or

            [ ]  to me and ______________________________, as joint tenants with
                 right of survivorship.

            and mail the certificate to me at the following address:

            ________________________________________________________
            ________________________________________________________
            ________________________________________________________

<PAGE>

            My mailing address for stockholder communications, if different from
the address listed above, is:

            ________________________________________________________
            ________________________________________________________
            ________________________________________________________

                                        Very truly yours,

                                        ________________________________________
                                        Optionee

                                        ________________________________________
                                        Print Name

                                        ________________________________________
                                        Date

                                        ________________________________________
                                        Social Security Number

                                       2<PAGE>

                                                                  EXHIBIT 10(gg)

                               SECOND AMENDMENT TO
                         THE SECOND AMENDED AND RESTATED
                                SYSCO CORPORATION
                      EXECUTIVE DEFERRED COMPENSATION PLAN

      THIS SECOND AMENDMENT TO THE SECOND AMENDED AND RESTATED SYSCO CORPORATION
EXECUTIVE DEFERRED COMPENSATION PLAN (this "Second Amendment").

      WHEREAS, SYSCO Corporation (the "Corporation") has adopted that certain
Second Amended and Restated SYSCO Corporation Executive Deferred Compensation
Plan (the "Plan") pursuant to a plan document effective as of April 1, 2002, as
amended by that certain First Amendment dated as of July 12, 2002; and

      WHEREAS, the Corporation has determined to amend the Plan so as to clarify
the definition of "Change of Control"; provide formal benefit claims and appeals
procedures; clarify certain powers of the Plan "Committee" (as such term is
defined in the Plan); provide for certain indemnification rights under the Plan;
and provide that certain types of Plan amendments may be effected by action of
the Plan Committee.

      NOW, THEREFORE, the Plan is hereby amended as follows:

(Capitalized terms used but not otherwise defined herein shall have the meaning
given them in the Plan.)

      1. Section 1.6 of the Plan is hereby amended in its entirety to read as
follows:

      "Change of Control. "Change of Control" means the occurrence of one or
more of the following events:

            (a) The acquisition by any individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act (a "Person") of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 20% or more of either (i) the then-outstanding shares of SYSCO
common stock (the "Outstanding SYSCO Common Stock") or (ii) the combined voting
power of the then-outstanding voting securities of SYSCO entitled to vote
generally in the election of directors (the "Outstanding SYSCO Voting
Securities"); provided, however, that, for purposes of this Section 1.6, the
following acquisitions shall not constitute a Change of Control: (1) any
acquisition directly from SYSCO, (2) any acquisition by SYSCO, (3) any
acquisition by any employee benefit plan (or related trust) sponsored or
maintained by SYSCO or any Affiliate, or (4) any acquisition by any corporation
pursuant to a transaction that complies with Sections 1.6(c)(i), 1.6(c)(ii) and
1.6(c)(iii);

<PAGE>

            (b) Individuals who, as of November 7, 2003, constitute the Board of
Directors (the "Incumbent Board") cease for any reason to constitute at least a
majority of the Board of Directors; provided, however, that any individual
becoming a director subsequent to November 7, 2003 whose election, or nomination
for election by SYSCO's stockholders, was approved by a vote of at least a
majority of the directors then comprising the Incumbent Board shall be
considered as though such individual were a member of the Incumbent Board, but
excluding, for this purpose, any such individual whose initial assumption of
office occurs as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents by or on behalf of a Person other than the
Board of Directors;

            (c) Consummation of a reorganization, merger, statutory share
exchange or consolidation or similar corporate transaction involving SYSCO or
any of its Affiliates, a sale or other disposition of all or substantially all
of the assets of SYSCO, or the acquisition of assets or stock of another entity
by SYSCO or any of its Affiliates (each, a "Business Combination"), in each case
unless, following such Business Combination, (i) all or substantially all of the
individuals and entities that were the beneficial owners of the Outstanding
SYSCO Common Stock and the Outstanding SYSCO Voting Securities immediately prior
to such Business Combination beneficially own, directly or indirectly, more than
60% of the then-outstanding shares of common stock and the combined voting power
of the then-outstanding voting securities entitled to vote generally in the
election of directors, as the case may be, of the corporation resulting from
such Business Combination (including, without limitation, a corporation that, as
a result of such transaction, owns SYSCO or all or substantially all of SYSCO's
assets either directly or through one or more subsidiaries) in substantially the
same proportions as their ownership immediately prior to such Business
Combination of the Outstanding SYSCO Common Stock and the Outstanding SYSCO
Voting Securities, as the case may be, (ii) no Person (excluding any corporation
resulting from such Business Combination or any employee benefit plan (or
related trust) of SYSCO or such corporation resulting from such Business
Combination) beneficially owns, directly or indirectly, 20% or more of,
respectively, the then-outstanding shares of common stock of the corporation
resulting from such Business Combination or the combined voting power of the
then-outstanding voting securities of such corporation, except to the extent
that such ownership existed prior to the Business Combination, and (iii) at
least a majority of the members of the board of directors of the corporation
resulting from such Business Combination were members of the Incumbent Board at
the time of the execution of the initial agreement or of the action of the Board
of Directors providing for such Business Combination; or

            (d) Approval by the stockholders of SYSCO of a complete liquidation
or dissolution of SYSCO."

      2. Article I of the Plan is hereby amended by deleting Section 1.37 of the
Plan in its entirety and adding the following definitions:

                                       2
<PAGE>

            "1.37 Affiliate. "Affiliate" means any entity with respect to which
SYSCO beneficially owns, directly or indirectly, at least 50% of the total
voting power of the interests of such entity and at least 50% of the total value
of the interests of such entity.

            1.38 Business Combination. "Business Combination" shall have the
meaning set forth in Section 1.6(c).

            1.39 Claimant. "Claimant" shall have the meaning set forth in
Section 7.7.

            1.40 ERISA. "ERISA" means the Employee Retirement Income Security
Act of 1974, as amended from time to time.

            1.41 Incumbent Board. "Incumbent Board" shall have the meaning set
forth in Section 1.6(b).

            1.42 Outstanding SYSCO Common Stock. "Outstanding SYSCO Common
Stock" shall have the meaning set forth in Section 1.6(a).

            1.43 Outstanding SYSCO Voting Securities. "Outstanding SYSCO Voting
Securities" shall have the meaning set forth in Section 1.6(a).

            1.44 Person. "Person" shall have the meaning set forth in Section
1.6(a)."

      3. Section 5.2 of the Plan is hereby amended by adding the following to
the end thereof:

            "In addition, the Compensation and Stock Option Committee of the
Board of Directors may, within its sole discretion, accelerate vesting under
this Section 5.2 when it determines that specific situations warrant such
action."

      4. Section 6.10 of the Plan is hereby amended by adding the following to
the end thereof:

            "Notwithstanding anything herein or otherwise to the contrary, the
Compensation and Stock Option Committee of the Board of Directors, may, within
its sole discretion and pursuant to an agreement approved by the Compensation
and Stock Option Committee, waive application of this Section 6.10, when it
determines that specific situations warrant such action."

      5. Section 7.1 of the Plan is hereby amended in its entirety to read as
follows:

            "Committee Appointment. The Committee will be appointed by the Board
of Directors or its designee. Each Committee member will serve until

                                       3
<PAGE>

his or her resignation or removal. The Board of Directors, or its designee, will
have the sole discretion to remove any one or more Committee members and appoint
one or more replacement or additional Committee members from time to time."

      6. Section 7.2 of the Plan is hereby amended in its entirety to read as
follows:

            "Committee Organization and Voting. The organizational structure and
voting responsibilities of the Committee shall be as set forth in the bylaws of
the Committee."

      7. Section 7.3(e)(i) of the Plan is hereby amended in its entirety to read
as follows:

            "(i) differences of opinion arising between the Company and a
Participant in accordance with Section 7.7, except when the difference of
opinion relates to the entitlement to, the amount of or the method or timing of
payment of a benefit affected by a Change of Control, in which event, such
difference of opinion shall be decided by judicial action; and"

      8. Section 7.3(f) of the Plan is hereby amended in its entirety to read as
follows:

            "(f) to delegate by written notice any plan administration duties of
the Committee to such individual members of the Committee, individual employees
of the Company, or groups of employees of the Company, as the Committee
determines to be necessary or advisable to properly administer the Plan; and"

      9. New Section 7.6 is hereby added to the Plan to read as follows:

            "7.6 Indemnification. To the extent permitted by law, members of the
Board of Directors, members of the Committee, employees of the Company, and all
agents and representatives of the Company shall be indemnified by the Company,
and saved harmless against any claims resulting from any action or conduct
relating to the administration of the Plan, except claims arising from gross
negligence, willful neglect or willful misconduct."

      10. New Section 7.7 is hereby added to the Plan to read as follows:

                                       4
<PAGE>

            "7.7 Claims Procedure. Any person who believes that he or she is
being denied a benefit to which he or she is entitled under the Plan (referred
to hereinafter as a "Claimant") must file a written request for such benefit
with the Committee; provided, however, that any claim involving entitlement to,
the amount of or the method or timing of payment of a benefit affected by a
Change of Control shall be governed by Section 7.3(e)(i). Such written request
must set forth the Claimant's claim and must be addressed to the Committee at
SYSCO's principal office.

                  (a) Initial Claims Decision. The Committee shall generally
provide written notice to the Claimant of its decision within 90 days (or 45
days for a disability-based claim) after the claim is filed with the Committee;
provided, however, that the Committee may have up to an additional 90 days (or
up to two 30-day periods for a disability-based claim), to decide the claim, if
the Committee determines that special circumstances require an extension of time
to decide the claim, and the Committee advises the Claimant in writing of the
need for an extension (including an explanation of the special circumstances
requiring the extension) and the date on which it expects to decide the claim.

                  (b) Appeals. A Claimant may appeal the Committee's decision by
submitting a written request for review to the Committee within 60 days (or 180
days for a disability-based claim) after the earlier of receiving the denial
notice or after expiration of the initial review period. Such written request
must be addressed to the Committee at SYSCO's principal office. In connection
with such request, the Claimant (and his or her authorized representative, if
any) may review any pertinent documents upon which the denial was based and may
submit issues and comments in writing for consideration by the Committee. If the
Claimant's request for review is not received within the earlier of 60 days (or
180 days for a disability-based claim) after receipt of the denial or after
expiration of the initial review period, the denial shall be final, and the
Claimant shall be barred and estopped from challenging the Committee's
determination.

                  (c) Decision Following Appeal. The Committee shall generally
make its decision on the Claimant's appeal in writing within 60 days (or 45 days
for a disability-based claim) following its receipt of the Claimant's request
for appeal; provided, however, that the Committee may have up to an additional
60 days (or 45 days for a disability-based claim) to decide the claim, if the
Committee determines that special circumstances require an extension of time to
decide the claim and the Committee advises the Claimant in writing of the need
for an extension (including an explanation of the special circumstances
requiring the extension) and the date on which it expects to decide the claim.
The Committee shall notify the Claimant of its decision on the Claimant's appeal
in writing, regardless of whether the decision is adverse.

                  (d) Decisions Final; Procedures Mandatory. A decision on
appeal by the Committee shall be binding and conclusive upon all persons, and
completion of the claims procedures described in this Section 7.7 shall be a
mandatory precondition to commencement of a legal or equitable action in

                                       5
<PAGE>

connection with the Plan by a person claiming rights under the Plan or by
another person claiming rights through such a person. The Committee may, in its
sole discretion, waive the procedures described in this Section 7.7 as a
mandatory precondition to such an action.

                  (e) Time for Filing Legal or Equitable Action. Any legal or
equitable action filed in connection with the Plan by a person claiming rights
under the Plan or by another person claiming rights through such a person must
commence not later than two years following the earlier of the Participant's
death, Disability, Retirement, or termination of employment."

      11. Section 9.1 of the Plan is hereby amended in its entirety to read as
follows:

            "Amendment or Termination of the Plan. The Board of Directors, the
Committee, or their designees, may amend this Plan at any time by an instrument
in writing without the consent of any adopting Subsidiary; provided, however,
that neither the Committee nor its designees shall have authority to terminate
this Plan or to make any amendment that would have a significant financial
statement or benefit impact on the Company. Notwithstanding the foregoing, in no
event shall the Board of Directors have the authority to terminate this Plan
during the two years following a Change of Control."

      Except as specifically amended hereby, the Plan shall remain in full force
and effect as prior to this Second Amendment.

                                       6
<PAGE>

      IN WITNESS WHEREOF, the Corporation has caused this Second Amendment to be
executed as of this 20th day of July , 2004, effective as of July 9, 2004.

                                  SYSCO CORPORATION

                                  By:           /s/ Diane Day Sanders
                                        ----------------------------------------
                                        Diane Day Sanders
                                        Senior Vice President, Finance and
                                        Treasurer

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]